Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus SODIUM CHLORIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus SODIUM CHLORIDE.
MAGNESIUM SULFATE IN PLASTIC CONTAINER vs SODIUM CHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Sodium chloride dissociates in body fluids into sodium and chloride ions, which are major determinants of extracellular fluid osmolality and volume. It maintains electrolyte balance, nerve impulse transmission, and muscle contraction.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
Intravenous: 0.9% sodium chloride (normal saline) infusion at 50-100 mL/hour for maintenance; dose depends on indication (e.g., 500-1000 mL bolus for hypovolemia). Maximum rate: 1 L/hour in emergencies.
None Documented
None Documented
Clinical Note
moderateSodium chloride + Tolvaptan
"The risk or severity of adverse effects can be increased when Sodium chloride is combined with Tolvaptan."
Clinical Note
moderateLithium cation + Sodium chloride
"Lithium cation may increase the excretion rate of Sodium chloride which could result in a lower serum level and potentially a reduction in efficacy."
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Variable and distribution-dependent; for acute changes, distribution half-life ~20 minutes; terminal half-life ~8-12 hours for total body sodium adjustment, clinically relevant for electrolyte correction
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Primarily renal (>90%) via glomerular filtration and tubular reabsorption; negligible biliary/fecal elimination (<1%)
Category C
Category A/B
Electrolyte
Electrolyte